The introduction of multi-omic research, the advancement of AI and machine learning to improve nearly every aspect of sequencing and data analysis, are just some of the big changes that will only become more prevalent in the future. We spoke to Angela Douglas MBE, Scientific Director of Genetics Laboratories at Liverpool Women’s Hospital, for her opinions on the changing nature of genomics and the trends to watch out for.
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
Multinational biopharmaceutical company UCB has agreed to invest £1 billion in UK research and development (R&D), the government has announced in its latest Life Sciences Sector Deal. In the deal, £75 million will be invested into the development of new AI driven diagnostic tests while £50 million will be invested in digital pathology programmes and £37.5 million into regional digital innovation hubs.
STAT news have put together a great article assessing the need for health care systems to get on top of the payment issue quickly. Give it a read!
The Novartis CAR-T cell therapy, Kymriah (tisagenlecleucel), will be made available to patients under the age of 25 via the Cancer Drugs Fund.
The scientific community has raised concerns about the state of UK immigration after a number of academics attending the Global Symposium on Health Systems Research were denied access to the country recently. At least 10 of the 200 attendees were affected by the policy, with arguments raised that such policies could impact academic co-operation.
Founder and CEO of Repositive, Fiona Nielsen ushers in the 10th anniversary of the US Genetic Information Nondiscrimination Act.
The NIH has committed up to $45.5M to support its Somatic Cell Genome Editing programme. The money will make up a series of grants to be paid over the next four fiscal years.
Americans are more likely to anticipate negative than positive effects from widespread use of gene-editing technology.